Fatty Liver and Liver Transplantation

Edith Koehler, Kymberly Watt, Michael Charlton

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis are common complications of overnutrition and obesity. In the setting of worsening epidemics of obesity in developed and developing countries, the global prevalence and impact of NAFLD seems likely to increase. The large number of patients at risk will translate into major challenges for the liver transplant community, affecting donors and recipients. The comorbidities and hepatic effects of obesity and NAFLD present important new challenges in the management of donors and recipients. This article addresses some of these challenges.

Original languageEnglish (US)
Pages (from-to)621-630
Number of pages10
JournalClinics in Liver Disease
Volume13
Issue number4
DOIs
StatePublished - Nov 2009

Fingerprint

Fatty Liver
Liver Transplantation
Obesity
Tissue Donors
Overnutrition
Liver
Developed Countries
Developing Countries
Comorbidity
Transplants
Non-alcoholic Fatty Liver Disease

Keywords

  • Cirrhosis
  • Fatty liver disease
  • Liver transplantation
  • Metabolic syndrome
  • Obesity
  • Steatohepatitis

ASJC Scopus subject areas

  • Hepatology

Cite this

Fatty Liver and Liver Transplantation. / Koehler, Edith; Watt, Kymberly; Charlton, Michael.

In: Clinics in Liver Disease, Vol. 13, No. 4, 11.2009, p. 621-630.

Research output: Contribution to journalArticle

Koehler, E, Watt, K & Charlton, M 2009, 'Fatty Liver and Liver Transplantation', Clinics in Liver Disease, vol. 13, no. 4, pp. 621-630. https://doi.org/10.1016/j.cld.2009.07.010
Koehler, Edith ; Watt, Kymberly ; Charlton, Michael. / Fatty Liver and Liver Transplantation. In: Clinics in Liver Disease. 2009 ; Vol. 13, No. 4. pp. 621-630.
@article{e7e5a09c71a7464fa9cd5b43b0250d82,
title = "Fatty Liver and Liver Transplantation",
abstract = "Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis are common complications of overnutrition and obesity. In the setting of worsening epidemics of obesity in developed and developing countries, the global prevalence and impact of NAFLD seems likely to increase. The large number of patients at risk will translate into major challenges for the liver transplant community, affecting donors and recipients. The comorbidities and hepatic effects of obesity and NAFLD present important new challenges in the management of donors and recipients. This article addresses some of these challenges.",
keywords = "Cirrhosis, Fatty liver disease, Liver transplantation, Metabolic syndrome, Obesity, Steatohepatitis",
author = "Edith Koehler and Kymberly Watt and Michael Charlton",
year = "2009",
month = "11",
doi = "10.1016/j.cld.2009.07.010",
language = "English (US)",
volume = "13",
pages = "621--630",
journal = "Clinics in Liver Disease",
issn = "1089-3261",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Fatty Liver and Liver Transplantation

AU - Koehler, Edith

AU - Watt, Kymberly

AU - Charlton, Michael

PY - 2009/11

Y1 - 2009/11

N2 - Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis are common complications of overnutrition and obesity. In the setting of worsening epidemics of obesity in developed and developing countries, the global prevalence and impact of NAFLD seems likely to increase. The large number of patients at risk will translate into major challenges for the liver transplant community, affecting donors and recipients. The comorbidities and hepatic effects of obesity and NAFLD present important new challenges in the management of donors and recipients. This article addresses some of these challenges.

AB - Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis are common complications of overnutrition and obesity. In the setting of worsening epidemics of obesity in developed and developing countries, the global prevalence and impact of NAFLD seems likely to increase. The large number of patients at risk will translate into major challenges for the liver transplant community, affecting donors and recipients. The comorbidities and hepatic effects of obesity and NAFLD present important new challenges in the management of donors and recipients. This article addresses some of these challenges.

KW - Cirrhosis

KW - Fatty liver disease

KW - Liver transplantation

KW - Metabolic syndrome

KW - Obesity

KW - Steatohepatitis

UR - http://www.scopus.com/inward/record.url?scp=70349774384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349774384&partnerID=8YFLogxK

U2 - 10.1016/j.cld.2009.07.010

DO - 10.1016/j.cld.2009.07.010

M3 - Article

C2 - 19818309

AN - SCOPUS:70349774384

VL - 13

SP - 621

EP - 630

JO - Clinics in Liver Disease

JF - Clinics in Liver Disease

SN - 1089-3261

IS - 4

ER -